Picard Medical, Inc.

Picard Medical, Inc.

PMI
Picard Medical, Inc.US flagNew York Stock Exchange American
0.09
USD
-0.03
- -
137.11MMarket Cap

Income Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
4
5
4
5
+ Sales & Services Revenue
4
5
4
5
- Cost of Revenue
9
7
5
5
+ Cost of Goods & Services
9
7
5
5
Gross Profit
-5
-2
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
6
13
14
13
+ Selling, General & Admin
4
11
10
10
+ Research & Development
2
2
3
3
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
-11
-16
-14
-13
- Non-Operating (Income) Loss
- -
- -
7
14
+ Interest Expense, Net
- -
- -
3
5
+ Interest Expense
- -
- -
3
5
- Interest Income
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
4
8
Pretax Income
-11
-16
-21
-27
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-11
-16
-21
-27
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-11
-16
-21
-27
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-11
-16
-21
-27
- Preferred Dividends
2
2
3
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-13
-18
-24
-27
EBIT
-11
-16
-14
-13
EBITDA
-11
-15
-13
-13
EBITDA Margin (%)
-255.82
-295.8
-299.91
-258
EBITA
-11
-16
-14
-13
Gross Margin (%)
-121.27
-45.83
-2.55
-4.13
Operating Margin (%)
-269.07
-307.4
-312.28
-268.36
Profit Margin (%)
-271.53
-308.72
-479.5
-546.6
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
1
1
1
1
Basic Weighted Avg Shares
72
72
72
36
Basic EPS, GAAP
-0.18
-0.25
-0.33
-0.75
Basic EPS from Cont Ops
-0.15
-0.22
-0.29
-0.75
Diluted Weighted Avg Shares
72
72
72
36
Diluted EPS, GAAP
-0.18
-0.25
-0.33
-0.75
Diluted EPS from Cont Ops
-0.15
-0.22
-0.29
-0.75

Balance Sheet (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
12
9
10
21
+ Cash, Cash Equivalents & STI
- -
- -
- -
7
+ Cash & Cash Equivalents
- -
- -
- -
7
+ ST Investments
- -
- -
- -
- -
+ Accounts & Notes Receiv
4
1
1
1
+ Accounts Receivable, Net
1
1
1
1
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
3
- -
- -
- -
+ Inventories
7
7
8
7
+ Raw Materials
5
6
6
6
+ Work In Process
1
1
3
3
+ Finished Goods
2
2
1
1
+ Inventory Adjustments
-2
-2
-2
-3
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
1
1
1
5
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
3
3
2
2
+ Property, Plant & Equip, Net
2
1
1
1
+ Property, Plant & Equip
2
2
2
1
- Accumulated Depreciation
- -
- -
1
1
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
1
1
1
1
+ Total Intangible Assets
1
1
1
1
+ Goodwill
1
1
1
1
+ Other Intangible Assets
1
1
1
1
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
Total Assets
15
11
12
23
+ Payables & Accruals
2
4
7
3
+ Accounts Payable
1
3
5
2
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
- -
1
1
1
+ ST Debt
1
4
20
7
+ ST Borrowings
1
4
20
6
+ ST Finance Leases
- -
- -
- -
- -
+ Other ST Liabilities
- -
1
8
9
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
8
9
Total Current Liabilities
3
9
35
19
+ LT Debt
1
5
1
- -
+ LT Borrowings
- -
4
- -
- -
+ LT Finance Leases
1
1
1
- -
+ Other LT Liabilities
- -
1
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
- -
1
- -
- -
Total Noncurrent Liabilities
1
6
1
- -
Total Liabilities
4
15
36
19
+ Preferred Equity and Hybrid Capital
20
20
20
- -
+ Share Capital & APIC
4
5
6
80
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
4
5
6
80
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-13
-29
-50
-77
+ Other Equity
- -
- -
- -
- -
Equity Before Minority Interest
11
-4
-24
4
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
11
-4
-24
4
Total Liabilities & Equity
15
11
12
23
Shares Outstanding
72
72
72
74
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
1
1
1
1
Net Debt
- -
8
20
-1
Net Debt to Equity
4.12
-227.9
-83.75
-26.47
Tangible Common Equity Ratio
-73.16
-249.29
-414.98
12.44
Current Ratio
4.04
0.95
0.28
1.11
Cash Conversion Cycle
- -
289.54
388.71
278.4

Cash Flow Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-11
-16
-21
-27
+ Depreciation & Amortization
1
1
1
1
+ Non-Cash Items
2
1
8
14
+ Stock-Based Compensation
- -
- -
1
1
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
2
1
7
13
+ Chg in Non-Cash Work Cap
-2
3
1
-3
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
-2
- -
-1
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
- -
3
3
-3
+ Inc (Dec) in Other
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-11
-11
-12
-16
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
17
+ Increase in Capital Stock
- -
- -
- -
17
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
6
8
12
11
+ Cash From Debt
6
9
13
19
+ Repayments of Debt
- -
-1
-1
-8
+ Other Financing Activities
- -
3
- -
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
6
11
12
27
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
-5
- -
- -
11
EBITDA
-11
-15
-13
-13
EBITDA Margin (%)
-255.82
-295.8
-299.91
-258
Free Cash Flow
-11
-11
-12
-16
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-5
-3
-25
Free Cash Flow per Basic Share
-0.15
-0.15
-0.16
-0.43
Price/Free Cash Flow
- -
- -
- -
-4.05
Cash Flow to Net Income
0.96
0.68
0.56
0.58
Capital Expenditures
- -
- -
- -
- -